2012 Outstanding Career Achievement: Roger O. McClellan, DVM, MMS, DSc (Honorary)

Roger O. McClellan, DVM, MMS, DSc (Honorary), Diplomate-ABT, Diplomate-ABVT, Fellow-ATS, AAAR, SRA, HPS and AAAS Member – Institute of Medicine

Dr. McClellan received his Doctor of Veterinary Medicine degree from Washington State University in 1960 and joined the Hanford Laboratories, Richland, WA, staff to conduct research on radionuclide toxicity in domestic animals. As a U.S. Atomic Energy Commission staff scientist (1965-1966), he provided oversight for the AEC’s radionuclide toxicity program. Beginning in 1966, he provided scientific leadership for the inhalation toxicology program of the Lovelace organization in Albuquerque, NM. This program achieved international recognition for research on the health effect of airborne radioactive materials and chemicals. As President of the Chemical Industry Institute of Toxicology (1988-1999), the Institute achieved international recognition for understanding how the mode of action of chemicals influences exposure-response relationships and informs extrapolation from animals to humans. Since 1999, he has served as an advisor to both public and private organizations on air quality issues, including the development of improved and safer technologies and products.

He has served as Adjunct Professor at eight universities and been active in a number of professional organizations, including service as President of the Society of Toxicology and the American Association for Aerosol Research. He is a Diplomate of the American Board of Toxicology and the American Board of Veterinary Toxicology and a Fellow of Academy of Toxicological Sciences, Society for Risk Analysis, Health Physics Society, Society for Risk Analysis, and American Association for Aerosol Research.

In 1990, he was elected to membership in the Institute of Medicine of the National Academy of Sciences. He received the International Aerosol Fellow Award for his contributions to aerosol science and technology and the Society of Toxicology’s Merit Award and Founders Award. In 2005, The Ohio State University awarded him an Honorary Doctor of Science degree. In 2008, he received the Washington State University Regents Distinguished Alumnus Award. He is a strong advocate of risk-based decision-making and the need to integrate data from epidemiological, controlled clinical, laboratory animal and cell studies to evaluate dose-response relationships for different technologies and products and to inform policy makers in developing standards and guidance to protect the health of workers and the public.